Bellicum Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Bellicum Pharmaceuticals, Inc. holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 23 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GOCAR-T and CASPACIDE. The owner is based in Houston, TX.

2130 W. Holcombe Drive, Suite 800

Houston, TX 77030

23 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Bellicum Pharmaceuticals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (23 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (7 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Bellicum Pharmaceuticals, Inc. have?

Bellicum Pharmaceuticals, Inc. has 23 U.S. trademarks filed with the USPTO. Of these, 2 registered, 19 abandoned, 2 cancelled.

What trademark classes does Bellicum Pharmaceuticals, Inc. file in?

Bellicum Pharmaceuticals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Bellicum Pharmaceuticals, Inc.'s most well-known trademarks?

Bellicum Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as GOCAR-T and CASPACIDE. These are among 2 currently registered trademarks in the portfolio.

What is Bellicum Pharmaceuticals, Inc.'s trademark registration success rate?

Bellicum Pharmaceuticals, Inc. has a 9% trademark registration rate, with 2 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.